Skip to main content
Premium Trial:

Request an Annual Quote

Through a Picture

Three dimensional facial scans could help in the diagnosis of rare genetic diseases, according to a new study.

Researchers from the US and Canada analyzed the facial images of more than 3,000 individuals with nearly 400 different syndromes alongside images from about 700 of their relatives and 3,000 unrelated individuals. As they report this week in Genetics in Medicine, the researchers developed and trained a machine learning algorithm to detect genetic syndromes from those images. After training, the algorithm was able to discern unaffected individuals with 96 percent accuracy, and the correct diagnosis was in its top 10 ranked list for 87.2 percent of the syndromic patients.

This, the researchers say, could help diagnose patients with genetic disorders more quickly and shorten the diagnostic odyssey many have to go through currently.

"Clinical genetics is labor-intensive," senior author Ophir Klein from the University of California, San Francisco, says in a statement. "Some clinics have a two-year waiting list to get in. Using 3D imaging could dramatically enhance clinicians' ability to diagnose children more quickly and inexpensively."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more